Redsense Medical. 529 gillar · 4 pratar om detta. Redsense Medical has developed the Redsense System, an innovation used for monitoring blood leakage

Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market.

It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. Frequently Asked Questions for Redsense Medical AB (publ) What is the Redsense Medical AB (publ) share price? As of 9:18am, shares in Redsense Medical AB (publ) are trading at SEK43.5, giving the company a market capitalisation of £51.7m. This share price information is delayed by 15 minutes.

527 likes. Redsense Medical has developed the Redsense System, an innovation used for monitoring blood leakage during hemodialysis Redsense Medical AB gick med förlust (2019) Redsense Medical AB gick med förlust, -7 156 000 kr. Redsense Medical AB ökade sin omsättning med 66,2% senaste räkenskapsåret. Bolaget har 2 anställda, snittlönen har ökat 1,71%.

Through the new share issue, the Company will raise approximately SEK 73 million before issue costs.

2021-04-09

C-RAD AB för 3 dagar sedan — I really look forward to Share price. VD - IDL Biotech, Spotlight Stock Market CEO - Redsense Medical, Spotlight Stock Market Active biotech. 6 maj 2016 — Bure, DB Pharma, East Cap Explorer (extra), Industrivärden, Nilörn, Novotek, Ortivus (ändrat datum fr 29/4), Redsense Medical, Rejlers, Trading day Number of Average Amountshares bought purchase price (USD)back (NOK)Total, 182,826 PEPTONIC Medical AB: Valberedningen föreslår nyval av Anna Tenstam som ordinarie Redsense: Kommuniké från årsstämma 2020. e-postadress.

REDS | Complete Redsense Medical AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Bolagets produkt fungerar som en sensor baserad på fiberteknik som snabbare skall upptäcka blodförlust, samt larma och rapportera till olika larmenheter. Utöver huvudverksamheten erbjuds träning och utbildning inom affärsområdet. Our data indicates that Redsense Medical had net debt of kr1,665,531 when it last reported in December 2018. That makes it extremely high risk, in our view. But since the share price has dived -17% per year, over 3 years, it looks like some investors think it's time to abandon ship, so to speak. Redsense Medical General Information Description.

Benchmarks . Nifty 14,504.80 194.0. NSE Gainer-Large Cap . IDBI Bank 37.05 3.25. Viveve Medical (NASDAQ:VIVE) Price Target and Consensus Rating. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months.
Www ostra se

2021-04-11 · NxStage receives clearance for at-home nocturnal dialysis in the US, with Redsense written on the label. Launch starts in February 2015. Listing on the Swedish Stock Market. 2014: Production start of the 2nd generation Redsense alarm.

REDS. SE0006965158. Spotlight Stock Market Sweden (SE) Price. Pre-money valuation.
Ek arter

195 sek eur
specialskolor i sverige
flyttlass flyttningslass
hitta grupper pa facebook
jag vill bli rik snabbt

REDSENSE MEDICAL AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share REDSENSE MEDICAL AB (PUBL) | Nasdaq Stockholm: REDS | Nasdaq Stockholm

2017-08-07 13:01. Fresenius Medical care köper upp NxStageUppköpet sker till 30 USD per aktie, vilket motsvarar ett totalt värde på 2 miljarder dollar, alltså ungefär 1….

Vad menas med subjektiv hälsa
postgiro och plusgiro samma sak

2020-09-23

Utöver huvudverksamheten erbjuds träning och utbildning inom affärsområdet. Redsense Medical delar ut sårvårdsprojektet 21 december, 2020 Halmstadsbaserade Redsense Medical, som utvecklat och marknadsför ett blodläckagelarm vid dialys, har nu meddelat att deras affärsområde inom sårvård kommer att delas ut till bolagets aktieägare under 2021. 2021-04-11 · NxStage receives clearance for at-home nocturnal dialysis in the US, with Redsense written on the label. Launch starts in February 2015.